View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. Technology
November 3, 1999

Semicon Heavyweights Join Scalpel R&D Program

By CBR Staff Writer

A group of semiconductor heavyweights have signed a joint agreement aimed at making Lucent Technologies Inc’s Scalpel lithography technology into a production lithography platform. The participants include Texas Instruments Inc, Motorola Inc and Samsung Electronic Co Ltd.

Scalpel projection electron lithography is being developed as a potential successor to current optical lithography methods for patterning smaller and more powerful chips. Using an electron source instead of a light source, projection electron technology is claimed to have the capability to print images with features smaller than 0.05 micron, compared to today’s 0.25 and 0.18 micron technology.

Other alternatives are also in the running to become future lithography technologies. Intel Corp, Advanced Micro Devices Inc and Motorola have all joined the US consortium developing extreme ultraviolet technology (EUV-LLC) for semiconductors with circuit linewidths less than a 100 nanometers (0.1 micron). While a European body – also backed by Lucent – is investigating ion-beam lithography.

Content from our partners
Rethinking cloud: challenging assumptions, learning lessons
DTX Manchester welcomes leading tech talent from across the region and beyond
The hidden complexities of deploying AI in your business

Websites in our network
Select and enter your corporate email address Tech Monitor's research, insight and analysis examines the frontiers of digital transformation to help tech leaders navigate the future. Our Changelog newsletter delivers our best work to your inbox every week.
  • CIO
  • CTO
  • CISO
  • CSO
  • CFO
  • CDO
  • CEO
  • Architect Founder
  • MD
  • Director
  • Manager
  • Other
Visit our privacy policy for more information about our services, how Progressive Media Investments may use, process and share your personal data, including information on your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.